Inge M. M. Lakeman

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort

Inge M. M. Lakeman, Mar Rodríguez‐Girondo, Andrew Lee et al. · Genetics in Medicine · 2020 · 89 citations · Full text

Medicine, Biostatistics, Oncology +17

Breast cancer risks associated with missense variants in breast cancer susceptibility genes

Leila Dorling, Sara Carvalho, Jamie Allen et al. · Genome Medicine · 2022 · 55 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i>breast cancer families

Inge M. M. Lakeman, Florentine Hilbers, Mar Rodríguez‐Girondo et al. · Journal of Medical Genetics · 2019 · 47 citations · Full text

Life Sciences, Genetics, Oncology +17

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Inge M. M. Lakeman, Alexandra J. van den Broek, Julien A M Vos et al. · Genetics in Medicine · 2021 · 38 citations · Full text

Medicine, Genetics, Oncology +17

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Inge M. M. Lakeman, Mar D M Rodríguez-Girondo, Andrew Lee et al. · Journal of Medical Genetics · 2022 · 37 citations · Full text

Life Sciences, Genetics, Oncology +17